Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Preferred Stock Liabilities (2020 - 2021)

NeuroPace (NPCE) has 2 years of Preferred Stock Liabilities data on record, last reported at $141.4 million in Q1 2021.

  • For Q1 2021, Preferred Stock Liabilities rose 92.23% year-over-year to $141.4 million; the TTM value through Mar 2021 reached $141.4 million, up 92.23%, while the annual FY2020 figure was $141.4 million, N/A changed from the prior year.
  • Preferred Stock Liabilities reached $141.4 million in Q1 2021 per NPCE's latest filing, roughly flat from $141.4 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $141.4 million in Q3 2020 and bottomed at $73.5 million in Q2 2020.